Zinthionein ZC: Completed Phase I/II enrollment

Adeona completed enrollment of 60 patients with AD or MCI in the second portion of the double-blind, placebo-controlled, U.S., pivotal Phase I/II CopperProof-2 trial to evaluate once-daily oral Zinthi...